China Approves ‘Seaweed Drug’ for Treatment of Alzheimer’s
By
Phil Gutis
| November 4th, 2019
Building on research into the connection between dementia, inflammation and bacteria in our digestive systems, Chinese officials awarded conditional approval to a seaweed-based drug…